Fellowship · Stanford, CA
Sponsored by Stanford Health Care
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 433 citations · Andrei Iagaru
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 317 citations · Andrei Iagaru
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
JCO oncology practice · 2026 · 19 citations · Erin Grady
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 39 citations · Erin Grady
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 96 citations · Erin Grady
Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025 · 35 citations ·
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025 · 26 citations · Helen Nadel
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
European urology · 2024 · 44 citations · Andrei Iagaru